CIMEX
Price
$27.05
Change
+$0.06 (+0.22%)
Updated
Jun 22 closing price
Net Assets
146.86B
HRLFX
Price
$10.59
Change
-$0.01 (-0.09%)
Updated
Jun 22 closing price
Net Assets
65.2M
Interact to see
Advertisement

CIMEX vs HRLFX

CIMEX vs HRLFX Comparison Chart in %
View a ticker or compare two or three
VS
CIMEX vs. HRLFX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Hold and HRLFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX has more cash in the bank: 147B vs. HRLFX (65.2M). HRLFX pays higher dividends than CIMEX: HRLFX (3.49) vs CIMEX (3.23). CIMEX was incepted earlier than HRLFX: CIMEX (24 years) vs HRLFX (9 years). HRLFX (1.30) is less costly to investors than CIMEX (0.83). HRLFX is a more actively managed with annual turnover of: 149.00 vs. CIMEX (65.00). CIMEX has a lower initial minimum investment than HRLFX: CIMEX (250) vs HRLFX (1000000). HRLFX annual gain was more profitable for investors over the last year : 18.59 vs. CIMEX (7.53). HRLFX return over 5 years is better than : 45.91 vs. CIMEX (24.64).
CIMEXHRLFXCIMEX / HRLFX
Total Expense Ratio0.830.9092%
Annual Report Gross Expense Ratio0.831.3064%
Fund Existence24 years9 years-
Gain YTD5.5789.95956%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets147B65.2M225,460%
Annual Yield % from dividends3.233.4993%
Returns for 1 year7.5318.5941%
Returns for 3 years34.5741.2084%
Returns for 5 years24.6445.9154%
Returns for 10 years78.32N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDDVX14.810.04
+0.27%
Janus Henderson U.S. Dividend Income D
EGOAX21.79N/A
N/A
Allspring Large Cap Core A
PRWAX79.53N/A
N/A
T. Rowe Price All-Cap Opportunities Fund
WPOIX11.10N/A
N/A
Weitz Partners III Opportunity Investor
GAOTX21.84N/A
N/A
JPMorgan Global Allocation R3